MENU

Can Hormel Foods (HRL) Stock Hit $30?

a manufacturer of meat products and other prepared foods

HRL
Daily Signal:
Gain/Loss:
A.I.Advisor
published price charts
Last 5 trading days
A.I.Advisor
Sep 02, 2026

Can Hormel Foods (HRL) Stock Hit $30?

Key Takeaways

  • The central question is whether Hormel Foods Corporation (HRL) can climb from roughly $22 to the $30 mark, a level matching the highest current analyst price target and representing about 36% upside.
  • The strongest bullish factors include a dividend yield above 5%, a portfolio reshaping toward higher-growth branded foods, and improving free cash flow.
  • The biggest obstacles are sluggish sales growth, depressed earnings from restructuring costs, and a trailing valuation that looks elevated relative to history.
  • Key technical levels include resistance near the 52-week high of $26.60 and support around $19.70, the 52-week low.
  • The key takeaway: $30 is achievable only over a longer horizon and depends on a sustained earnings and margin recovery, not a short-term catalyst.

Why Investors Are Watching the $30 Level

Hormel Foods has spent years as a defensive staple that income investors favored for its reliable dividend. The $30 price target now carries extra significance because it aligns with the highest estimate among the analysts covering the stock, most of whom cluster their price targets in the mid-$20s. In other words, $30 represents a meaningful step-change in how the market would need to value the company, rather than a routine recovery toward prior highs.

Company Overview

Founded in 1891 and headquartered in Austin, Minnesota, Hormel Foods develops and markets branded food products across retail, foodservice, and international segments. Its portfolio spans well-known names such as SPAM, Jennie-O, Planters, Applegate, Skippy, and Columbus. The company has been transitioning away from commodity meat processing toward a more focused, higher-margin branded food business, a strategy that has included divestitures and a corporate restructuring plan.

Current Market Position

Shares recently traded near $22, well below the 52-week high of $26.60 and above the 52-week low of $19.70. The stock's long-term trend remains under pressure, as it sits far below its all-time high near $55 set in April 2022. With a beta of roughly 0.3 to 0.4, Hormel is a low-volatility name, which means price moves tend to be gradual rather than explosive. That low beta is a relevant constraint when evaluating a target 36% above the current quote.

What Could Drive the Next Leg Higher

A credible path toward $30 would require several conditions to align. First, the company's portfolio reshaping would need to translate into durable organic sales growth, reversing the modest revenue declines reported in recent quarters. Second, cost-discipline initiatives would need to lift operating margins meaningfully, allowing earnings to recover from their currently depressed base. Third, the roughly 5.3% dividend yield, supported by a $1.17 annual payout, provides a cushion that could attract income-oriented capital while management executes its turnaround.

What Could Prevent the Move

The most direct obstacle is fundamental: sales have been shrinking. In the most recently reported fiscal quarter, net sales of about $2.96 billion declined 2.4% year over year, while restructuring and divestiture costs continue to weigh on reported earnings. The company guided to fiscal 2026 earnings per share (EPS) of $1.45 to $1.51, a modest figure that keeps the stock's price-to-earnings ratio elevated on a trailing basis. Without a clear acceleration in EPS growth, a re-rating toward $30 would require the market to assign the shares a substantially richer multiple, which is difficult to justify while revenue remains soft.

Analyst Opinions and Price Targets

Wall Street's view is cautious. The consensus rating on the stock is "Hold," and the average price target sits near $26, with individual estimates ranging from roughly $23 to $30. Barclays maintains a "Buy" rating with the $30 target, representing the optimistic end of the spectrum, while most other firms hold targets in the mid-to-upper $20s. Notably, some firms have trimmed their targets following weaker quarterly results, underscoring that the $30 objective is not yet the base case for the Street.

Technical Levels That Matter

From a technical standpoint, the first major hurdle is the $26.60 level, the 52-week high. Before $30 becomes realistic, shares would need to reclaim and hold above that zone, which also sits near the top of the analyst target range. On the downside, the $19.70 low is the primary support, with the $22 area acting as a nearer-term floor following the stock's recent stabilization. A decisive move through the mid-$20s would signal that the demand side is strengthening, while a break below $22 would call the recovery thesis into question.

AI Daily Buy/Sell Signals

Traders looking to track changing conditions in names like Hormel Foods can turn to Tickeron's AI Daily Buy/Sell Signals. This tool uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical behavior, and AI-driven analysis. Rather than replacing independent judgment, the signals are designed to help traders discover opportunities, monitor existing positions, and identify shifting market trends more efficiently. For those seeking a data-driven complement to their own research, exploring these AI-generated signals can be a practical next step.

Final Assessment

A move to $30 appears possible but is best viewed as a multi-year scenario rather than a near-term expectation. The supportive elements—an attractive dividend yield, a simplified portfolio, and improving cash flow—are real, but they must first convert into sustained revenue growth and margin expansion before the market is likely to reward the stock with a higher multiple. The primary risks are continued sales softness and an earnings base that remains too thin to justify a significantly higher price-to-earnings ratio at present. Investors should monitor quarterly organic sales trends, operating margin progress, and the stock's ability to reclaim the $26.60 area, since that level is the clearest technical gateway to any eventual run toward $30.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

View a ticker or compare two or three
HRL
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

HRL and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, HRL has been loosely correlated with HSY. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if HRL jumps, then HSY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRL
1D Price
Change %
HRL100%
+0.27%
HSY - HRL
44%
Loosely correlated
+0.81%
CAG - HRL
43%
Loosely correlated
+0.43%
GIS - HRL
43%
Loosely correlated
-1.24%
TR - HRL
42%
Loosely correlated
-0.92%
MDLZ - HRL
42%
Loosely correlated
+1.36%
More

Groups containing HRL

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRL
1D Price
Change %
HRL100%
+0.27%
Food: Major Diversified
industry (63 stocks)
1%
Poorly correlated
-1.51%